Page last updated: 2024-08-26

beauvericin and Lung Neoplasms

beauvericin has been researched along with Lung Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, BF; Jow, GM; Lin, HI; Lu, CL1
Chen, BF; Chou, CJ; Jow, GM; Lee, YJ; Lin, HI; Lu, JL; Tsai, MC1

Other Studies

2 other study(ies) available for beauvericin and Lung Neoplasms

ArticleYear
Beauvericin-induced cell apoptosis through the mitogen-activated protein kinase pathway in human nonsmall cell lung cancer A549 cells.
    The Journal of toxicological sciences, 2016, Volume: 41, Issue:3

    Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Butadienes; Carcinoma, Non-Small-Cell Lung; Cell Survival; Depsipeptides; Dose-Response Relationship, Drug; G1 Phase Cell Cycle Checkpoints; Lung Neoplasms; Mitogen-Activated Protein Kinases; Nitriles; Protein Kinase Inhibitors; Signal Transduction

2016
Involvement of Bcl-2 family, cytochrome c and caspase 3 in induction of apoptosis by beauvericin in human non-small cell lung cancer cells.
    Cancer letters, 2005, Dec-18, Volume: 230, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspase 3; Caspases; Cell Line, Tumor; Cell Survival; Cytochromes c; Depsipeptides; DNA Fragmentation; Humans; In Situ Nick-End Labeling; Lung Neoplasms; Membrane Potentials; Mitochondria; Proto-Oncogene Proteins c-bcl-2

2005